Foghorn Therapeutics Inc.
FHTXBiotechnology
$2.09−1.88%As of Oct 29vs prior close
- Market cap
- $124.1M
- P/E (TTM)
- –
- From 52W high
- −70.44%
- EPS (LTM)
- -$0.99
- Revenue (LTM)
- $36.7M
- Net margin
- -175.78%
- Dividend yield
- 0.00%
Nomior Score
24
Steady ProfileSpeculativeBottom 10% of the scored universe
Growth51
Quality37
Value39
Momentum33
Resilience21
Growth
+135.14%revenue a year over 5 fiscal years
YE20 $430KLTM $36.7M
Connections
Revenue to profitQ2 YE26
The operating loss was 55% of revenue, narrower by 224 pts on a year.
Who owns it
2funds